Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exosomal microRNAs (exo-miRNAs) are a class of small, non-coding RNA molecules typically 19-25 nucleotides in length that are packaged into exosomes for intercellular communication (Valadi et al., 2007, Nature Cell Biology). These molecules are secreted by various cell types into the extracellular environment and are protected from enzymatic degradation by the lipid bilayer of the exosome (Zhang et al., 2015, Nature). Upon uptake by recipient cells, exo-miRNAs function as key regulators of gene expression by binding to complementary sequences on target messenger RNAs (mRNAs), leading to translational repression or mRNA cleavage (NIH/NCBI). In the context of disease, exo-miRNAs are frequently dysregulated and contribute to the pathogenesis of cancer, cardiovascular disorders, and neurodegenerative conditions by modulating the microenvironment and promoting processes like angiogenesis or immune evasion (PubMed). As therapeutic targets, they can be modulated using antisense oligonucleotides to inhibit oncogenic miRNAs or supplemented with miRNA mimics to restore tumor-suppressive functions (ClinicalTrials.gov). Furthermore, their stability in biofluids makes them highly attractive candidates for non-invasive liquid biopsy biomarkers in precision medicine. The development of exosome-based delivery systems for these miRNAs represents a significant frontier in targeted drug delivery and regenerative medicine.
Exosomal microRNAs act by binding to the 3' untranslated region (UTR) of target mRNAs within recipient cells, leading to mRNA degradation or translational inhibition through the RNA-induced silencing complex (RISC) (NIH/NCBI).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exosomal microRNA (exo-miRNA).